NovaBay Pharmaceuticals CEO Justin Hall's 2020 pay jumps 129% to $747K

NovaBay Pharmaceuticals reports 2020 executive compensation

By ExecPay News

Published: April 7, 2021

NovaBay Pharmaceuticals reported fiscal year 2020 executive compensation information on April 7, 2021.
In 2020, four executives at NovaBay Pharmaceuticals received on average a compensation package of $466K, a 108% increase compared to previous year.
Average pay of disclosed executives at NovaBay Pharmaceuticals
20082010201220152017201920210300K600K900K1.2M
  • Salary
  • Stock
  • Options
  • Bonus
  • Other
Justin M. Hall, Chief Executive Officer, received $747K in total, which increased by 129% compared to 2019. 46% of Hall's compensation, or $347K, was in option awards. Hall also received $114K in bonus, $286K in salary, as well as $720 in other compensation.
Andrew Jones, Chief Financial Officer, received a compensation package of $737K. 45% of the compensation package, or $334K, was in option awards.
Wang Xu, Senior Manager and Controller, earned $299K in 2020, a 78% increase compared to previous year.
Jason Raleigh, Chief Financial Officer, received $83K in 2020, which decreases by 75% compared to 2019.

Related executives

Justin Hall

NovaBay Pharmaceuticals

Chief Executive Officer

Andrew Jones

NovaBay Pharmaceuticals

Chief Financial Officer

Wang Xu

NovaBay Pharmaceuticals

Senior Manager and Controller

Jason Raleigh

NovaBay Pharmaceuticals

Chief Financial Officer

You may also like

Source: SEC filing on April 7, 2021.
0